IBC Virtual Symposium: Gene Therapy Research in the Age of COVID-19

▤ Summary

In 2019, an all-time high number of investigational new drug (IND) applications were submitted for gene therapy products in clinical research. Additionally, with coronavirus (SARS-CoV-2) and the disease it causes (COVID-19), vaccine research has been in the limelight for much of 2020. While great strides have been made in genetic research, to continue, some remaining obstacles need to be addressed. In an effort to begin conversations about these obstacles, Advarra presents its first virtual symposium, Gene Therapy Research in the Age of COVID-19: Study Startup Success for Infectious Disease, Oncology, and Rare Disease Research. This symposium will feature a virtual panel discussion on emerging issues in gene therapy research.

▦ Linked Companies

Advarra

$250M to $500M